LAS VEGAS, May 27, 2015 /PRNewswire/ -- DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc. (OTCQB: DIGPD) opened the doors of its Las Vegas marijuana analytical testing laboratory for business today. Equipped with state of the art analytical instrumentation and operated under the direction of Cindy Orser, PhD, DigiPath Lab's flagship facility offers cannabis growers and marijuana-based product-makers fast and reliable results.

"This is a great day for the patients of Nevada who will benefit from medical marijuana," said DigiPath Labs president Todd Denkin. "Our analysis not only helps product producers and dispensaries screen out products with dangerous levels of contaminants, we also quantify the medicinal compounds present in samples, so patients and caregivers can choose products that have been shown to relieve their specific symptoms."

Surprisingly, compulsory cannabis testing is relatively new. The State of Colorado only began requiring product testing a year ago after a series of overdoses on edibles made the news. Washington State did not begin requiring testing for potency, contaminants, moisture and microbiology testing until 2013 when recreational cannabis became legal, even though the medicinal use of marijuana became legal in 1998.

Nevada State officials delayed the launch of the commercial cannabis industry as they debated which tests should be required for cannabis products sold in the Silver State.

"We are pleased that Nevada Division of Public and Behavioral Health officials took their time and exercised great care while developing a list of requirements for marijuana testing," said Dr. Orser. "Cannabis contains hundreds of different medicinal compounds—each effective for treating specific medical conditions—and we haven't adopted a standardized way of growing it. Testing cannabis products for unhealthy levels of contaminants and medicinal potency is the only way to ensure product safety and potential efficacy."

For more information about DigiPath Labs, go to www.digipathlabs.com.

About DigiPath, Inc. (OTCQB: DIGPD)

DigiPath, Inc., supports the cannabis industry's best practices for reliable testing, education, and training, and brings unbiased cannabis news coverage to the nation. DigiPath's four business units are DigiPath Labs, TNM News Corp., DigiPath Corp., and DigiPath U.

Information about Forward-Looking Statements

This press release contains "forward-looking statements" that include information relating to future events. Forward-looking statements are based on information available at the time they are made, and are subject to risks and uncertainties that could cause actual performance to differ materially from those stated. For a description of the risk factors and uncertainties affecting DigiPath, please refer to the Company's recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements.

Media contact:

DigiPath, Inc.
Investor Relations
(888) 552-4440
IR@digipath.com